January/February

Real-world evidence is becoming increasingly important for the development of treatment strategies in oncology.

Specialty pharmacies function as a valuable intermediary between stakeholders for the distribution of drug information, provision of exceptional care for complex patients, and engagement in postmarketing surveillance.

The second part of a comprehensive review of the specialty pharmaceuticals approved by the FDA in 2017.

Chemotherapy, antivirals, and hormone therapies are among the drugs addressed in the 2016 National Institute for Occupational Safety and Health list.

Technology-driven customer intelligence and analytics allow specialty pharmacies to connect with patients before they drift from proper habits.

When planning for a specialty pharmacy within a health system, 3 business models should be considered: build, partner, and outsource.

In 2018, watch for novel cancer drugs and several new orphan drugs to affect the market.

Strategies for approaching the numerous developing trends in the specialty pharmacy market are vital to a successful plan of action in 2018.

Shadow pricing of diabetes medications is among the key issues confronting patients managing this chronic disease.